SCHEMBL6834587

SCHEMBL6834587

Cn1c(C(=O)Nc2ccc(C#N)cc2C(=O)O)cc2cccc(OCc3ccco3)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
ALB P02768 3/20 0.37
ALDH1A1 P00352 6/20 0.37
HSD17B10 Q99714 4/20 0.37
KDM4E B2RXH2 3/20 0.37
LMNA P02545 2/20 0.37
MAPK1 P28482 1/20 0.37
POLB P06746 4/20 0.37
MAPT P10636 3/20 0.37
TSHR P16473 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ESR2 Q92731 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TRPM4 Q8TD43 1/20 0.36
PYGL P06737 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6814183 0.87 MRGPRX4 (0.43) RXFP1ALBLMNAMAPTMEN1
SCHEMBL6830475 0.87 ALB (0.46) RXFP1ALBLMNAMAPTTRPM4
SCHEMBL6834068 0.87 ALB (0.43) RXFP1ALBHSD17B10LMNAPOLB
SCHEMBL6833983 0.86 AKR1C2 (0.42) RXFP1ALBALDH1A1LMNAMAPT
SCHEMBL6834153 0.86 PLK1 (0.44) RXFP1ALBALDH1A1LMNAMAPT
SCHEMBL6830121 0.85 ALB (0.40) RXFP1ALBHSD17B10LMNAMAPT
SCHEMBL6833872 0.84 KDM1A (0.43) RXFP1ALBLMNAMAPTTRPM4
SCHEMBL6713474 0.84 RXFP1 (0.33) RXFP1ALDH1A1HSD17B10KDM4ELMNA
SCHEMBL6707891 0.83 HSD17B10 (0.33) RXFP1ALDH1A1HSD17B10KDM4ELMNA
SCHEMBL6834267 0.83 KDM1A (0.42) RXFP1ALBLMNAMAPTTRPM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US claimed
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 CYP1A2 710/4885RXFP1 3523/4885ALB 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.